DEXCOM INC Quarterly Deferred Income Tax Expense (Benefit) in USD from Q2 2017 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Dexcom Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q2 2017 to Q3 2025.
- Dexcom Inc Deferred Income Tax Expense (Benefit) for the quarter ending September 30, 2025 was $118M.
- Dexcom Inc Deferred Income Tax Expense (Benefit) for the twelve months ending September 30, 2025 was $128M.
- Dexcom Inc annual Deferred Income Tax Expense (Benefit) for 2024 was -$43.8M, a 20.4% increase from 2023.
- Dexcom Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$55M, a 155% decline from 2022.
- Dexcom Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$21.6M, a 237% decline from 2021.
Deferred Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)